Youngy Health Co., Ltd. (300247) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Youngy Health Co., Ltd.

Why is Youngy Health Co., Ltd. ?

With a growth in Net Profit of 144.92%, the company declared Outstanding results in Sep 25

The company has declared positive results for the last 6 consecutive quarters
PRE-TAX PROFIT(Q) At CNY 38.49 MM has Grown at 271.77%
NET PROFIT(Q) At CNY 20.2 MM has Grown at 231.48%
ROCE(HY) Highest at 7.06%

With ROE of 7.74%, it has a attractive valuation with a 2.99 Price to Book Value

Over the past year, while the stock has generated a return of 17.14%, its profits have risen by 104.5% ; the PEG ratio of the company is 0.4

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Youngy Health Co., Ltd. should be less than 10%
Overall Portfolio exposure to Tour, Travel Related Services should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Tour, Travel Related Services)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Youngy Health Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Youngy Health Co., Ltd.

17.1%

1.85

41.89%

China Shanghai Composite

15.17%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

9.28%

EBIT Growth (5y)

18.52%

EBIT to Interest (avg)

33.28

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.57

Sales to Capital Employed (avg)

0.60

Tax Ratio

25.24%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

6.86%

ROE (avg)

5.32%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.99

EV to EBIT

27.43

EV to EBITDA

21.32

EV to Capital Employed

6.72

EV to Sales

3.31

PEG Ratio

0.37

Dividend Yield

ROCE (Latest)

24.49%

ROE (Latest)

7.74%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

25What is working for the Company

PRE-TAX PROFIT(Q)

At CNY 38.49 MM has Grown at 271.77%

NET PROFIT(Q)

At CNY 20.2 MM has Grown at 231.48%

ROCE(HY)

Highest at 7.06%

NET SALES(Q)

At CNY 219.13 MM has Grown at 53.87%

RAW MATERIAL COST(Y)

Fallen by -72.19% (YoY

CASH AND EQV(HY)

Highest at CNY 1,269.28 MM

-2What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at -38.59 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 10.58 times

Here's what is working for Youngy Health Co., Ltd.

Pre-Tax Profit

At CNY 38.49 MM has Grown at 271.77%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 20.2 MM has Grown at 231.48%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales

At CNY 219.13 MM has Grown at 53.87%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Cash and Eqv

Highest at CNY 1,269.28 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -72.19% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Youngy Health Co., Ltd.

Debt-Equity Ratio

Highest at -38.59 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 10.58 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio